Zaid Admani

The previous offer was a mix of cash and Netflix stock, but now if the Warner shareholders approve this deal, they'll receive straight cash from Netflix.

Warner shareholders will vote on this deal in April.

I guess Netflix felt the pressure from Paramount and their hostile bid of $30 a share, all cash for the entire company.

And Netflix decided to improve their offer to remove any objections and speed up the sale.

The Warner board has rejected Paramount's offer multiple times.

They think that the Netflix offer is bad.

better we'll see what Paramount does next maybe they'll offer even more money for Warners to convince shareholders to go with their offer but low-key I'm kind of getting sick of this story you know I just want one of them to win close the deal combine it with their existing streaming service so I have one less streaming service I have to pay for I know that's wishful thinking this story is probably going to drag on for another year as it faces regulatory hurdles to get approved

Let's talk about some stocks making moves today.

Shares of Wrapped Therapeutics are absolutely ripping higher this morning after the pharma giant GSX agreed to buy the company for $58 per share in cash, valuing the deal at $2.2 billion.

Wrapped makes a key drug called Ozu Reprubart, which targets the immune response behind allergic reactions.

So GSX, which is a $100 billion company, will add this drug to their portfolio, which already includes asthma treatments, shingle vaccines, and HIV therapies.

As a result, RAP shares are up more than 60% on this news, and I feel like that's pretty typical in any pharmaceutical buyout.

By the way, pharma M&As, man, they are heating up right now.

Now on the flip side, shares of 3M are sliding this morning, despite the company reporting solid earnings.

3M beat expectations on both profits and revenues in Q4, and management forecast three to 4% revenue growth in 2026, which was pretty much in line with what analysts were expecting.

Now, a 3% growth might not sound exciting, but this is a company that's been publicly traded since the early 80s.

This isn't a hyper growth tech stock.

It's a mature industrial company and they make products like industrial adhesives and things like post-it notes and scotch tape.

At this stage, the pitch for 3M is an explosive growth.

It's stability, cashflow, and dividends.